FDAFDA · Food and drugs·Recall number D-0160-2023
Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 0527-1632-10
Published January 25, 2023 · Recall initiated: November 9, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurity/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Lannett Company Inc.
- Distributor
- Nationwide USA
- Lot
- Lots: 20256318A (12/2022), 20256321A (12/2022), 21000238A (01/2023)
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.